Skip to main content
. 2021 May 26;11(8):2150–2171. doi: 10.1016/j.apsb.2021.05.020

Figure 1.

Figure 1

Milestones of in vivo delivery of CRISPR-Cas9 therapeutics. Key developmental milestones for in vivo delivery of CRISPR-Cas9. AAV: adeno-associated virus, NP: nanoparticle, LNP: lipid nanoparticle. CRISPR: clustered regularly interspaced short palindromic repeats, Cas9: CRISPR-associated protein 9.